Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.94 million shares were traded. ACRS stock price reached its highest trading level at $1.59 during the session, while it also had its lowest trading level at $1.54.
Ratios:
For a deeper understanding of Aclaris Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.99 and its Current Ratio is at 3.99. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACRS now has a Market Capitalization of 168710880 and an Enterprise Value of 57357360. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.99 while its Price-to-Book (P/B) ratio in mrq is 1.08. Its current Enterprise Value per Revenue stands at 3.064 whereas that against EBITDA is -1.098.
Stock Price History:
The Beta on a monthly basis for ACRS is 0.56, which has changed by 0.35652173 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -30.88%, while the 200-Day Moving Average is calculated to be -16.47%.
Shares Statistics:
For the past three months, ACRS has traded an average of 871.76K shares per day and 1095980 over the past ten days. A total of 107.85M shares are outstanding, with a floating share count of 91.37M. Insiders hold about 15.34% of the company’s shares, while institutions hold 68.59% stake in the company. Shares short for ACRS as of 1740700800 were 4764970 with a Short Ratio of 5.47, compared to 1738281600 on 3916170. Therefore, it implies a Short% of Shares Outstanding of 4764970 and a Short% of Float of 5.2800003.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
